TAD analysis for <i>Sox10.</i> by Hongjoo An (21703199)

Supplementary file 1_Therapeutic efficacy and safety of Xuebijing in traumatic brain injury: systematic review and meta-analysis.docx by Yihan Sun (3432287)

“…XBJ also markedly decreased systemic inflammatory biomarkers, including C-reactive protein (CRP; SMD = −1.34), tumour necrosis factor-alpha (TNF-α; SMD = −0.98), and interleukin-6 (IL-6; SMD = −0.98) (all p < 0.01). …”

Study group background characteristics. by Zicheng Hu (3825313)

“…This relationship changed markedly with the development of <b><i>HAD</i></b> and the underlying direct neuropathic parenchymal CNS infection, i.e., <b><i>HIVE</i></b>, in which the CSF HIV-1 RNA concentrations reached high levels, and the differences between it and the blood viral load decreased. …”